MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ENLV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Enlivex Therapeutics (ENLV) Earnings Date & Reports

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

ENLV is expected to report earnings to -15 cents per share on August 18

Enlivex Therapeutics ENLV Stock Earnings Reports
Q2'25
Est.
$-0.15
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.07
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.03
The last earnings report on May 23 showed earnings per share of -15 cents, beating the estimate of -15 cents. With 170.25K shares outstanding, the current market capitalization sits at 34.11M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ENLV
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For ENLV
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ENLV showed earnings on May 23, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
14 Einstein Street
Phone
+972 26208072
Employees
77
Web
https://www.enlivex.com